Cara Therapeutics

2 followers

‌

Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.

Industries

Headquarters

Stage

Employees

Links

Org chart

Christopher Posner

CEO, President & Director

Christopher Posner

Collapse

Ryan Maynard

CFO

Iris Francesconi

Chief Strategy Officer & Head of Investor Relations

Frédérique Menzaghi

Chief Scientific Officer, SVP Research & Development

Jo Goncalves

Chief Medical Officer

Scott Terrillion

General Counsel, Secretary & Chief Compliance Officer

Eric Vandal

SVP, Commercial

Beth Weinberg

SVP, Regulatory Affairs & QA

Teams

View all

CEO and Executive Team

8 members

Leadership Team

8 members

Board of Directors

4 members

Discover similar companies

Sorrento Therapeutics

2 followers

Sutro Biopharma

2 followers

Otonomy

1 follower

OncoSec

1 follower

Pulse Biosciences

1 follower